Frailty and benign prostatic hyperplasia: The thrilling underlying impact

Arch Ital Urol Androl. 2022 Sep 27;94(3):345-349. doi: 10.4081/aiua.2022.3.345.


Background: World population is aging. The number of individuals aged over 65 are expected to be 71 million only in the US. 43% of this population will be men. Benign prostatic hyperplasia (BPH), defined as the benign neoplasm of the prostate gland affects 8% of men by their forties, but 90% of men over 90 years old. Lower urinary tract symptoms (LUTS) can be caused by an enlarged prostate, and it seems to be associated more with older and frailer individuals.

Methods: The purpose of this study is to review the potential interplay between frailty syndrome and benign prostatic hyperplasia. A thorough MEDLINE/PubMed non-systematic literature review was conducted from 1990 to March of 2022. The terms used for the search were "frailty and benign prostatic hyperplasia" and "low muscle mass and benign prostatic hyperplasia".

Results: It seems that, frailty poses a negative impact on the prognosis of patients with BPH, as it is associated with increased incidence of LUTS. In addition, frailty seems to be a strong predictor concerning surgical procedure failure and mortality following invasive procedures for BPH. Prostatic stent placement on the other hand appears to be the ideal solution for frail patients.

Conclusions: BPH has a strong association with frailty and increasing age.

Publication types

  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Frail Elderly
  • Frailty* / complications
  • Frailty* / epidemiology
  • Humans
  • Lower Urinary Tract Symptoms* / epidemiology
  • Lower Urinary Tract Symptoms* / etiology
  • Lower Urinary Tract Symptoms* / surgery
  • Male
  • Prostate
  • Prostatic Hyperplasia* / surgery